Mirum Pharmaceuticals (MIRM) EBIAT: 2020-2025
Historic EBIAT for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $2.9 million.
- Mirum Pharmaceuticals' EBIAT rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
- As of Q3 2025, Mirum Pharmaceuticals' EBIAT stood at $2.9 million, which was up 149.56% from -$5.9 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' EBIAT registered a high of $57.5 million during Q4 2021, and its lowest value of -$74.0 million during Q2 2023.
- Moreover, its 3-year median value for EBIAT was -$23.8 million (2024), whereas its average is -$24.5 million.
- In the last 5 years, Mirum Pharmaceuticals' EBIAT surged by 254.68% in 2021 and then tumbled by 175.01% in 2023.
- Mirum Pharmaceuticals' EBIAT (Quarterly) stood at $57.5 million in 2021, then tumbled by 163.31% to -$36.4 million in 2022, then climbed by 2.12% to -$35.7 million in 2023, then soared by 33.28% to -$23.8 million in 2024, then surged by 120.41% to $2.9 million in 2025.
- Its last three reported values are $2.9 million in Q3 2025, -$5.9 million for Q2 2025, and -$14.7 million during Q1 2025.